Your browser doesn't support javascript.
loading
A fluorescent biosensor for cardiac biomarker myoglobin detection based on carbon dots and deoxyribonuclease I-aided target recycling signal amplification.
Chen, Jishun; Ran, Fengying; Chen, Qinhua; Luo, Dan; Ma, Weidong; Han, Tuo; Wang, Ceming; Wang, Congxia.
Afiliación
  • Chen J; Department of Cardiology, The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an Shanxi 710004 China wcx622@163.com +86-02987679770.
  • Ran F; Affiliated Dongfeng Hospital, Hubei University of Medicine Shiyan Hubei 442008 China.
  • Chen Q; Affiliated Dongfeng Hospital, Hubei University of Medicine Shiyan Hubei 442008 China.
  • Luo D; Affiliated Dongfeng Hospital, Hubei University of Medicine Shiyan Hubei 442008 China.
  • Ma W; Shennongjia Golden Monkey Key Laboratory of Conservation Biology in Hubei Province Shennongjia Hubei 442400 China.
  • Han T; Affiliated Dongfeng Hospital, Hubei University of Medicine Shiyan Hubei 442008 China.
  • Wang C; Department of Cardiology, The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an Shanxi 710004 China wcx622@163.com +86-02987679770.
  • Wang C; Department of Cardiology, The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an Shanxi 710004 China wcx622@163.com +86-02987679770.
RSC Adv ; 9(8): 4463-4468, 2019 01 30.
Article en En | MEDLINE | ID: mdl-35520187
A sensitive biosensor using carbon dots and deoxyribonuclease I-aided target recycling signal amplification has been developed to detect myoglobin (MB), which is an important cardiac biomarker and plays a major role in the diagnosis of acute myocardial infarction (AMI). Here, in the absence of MB, the MB aptamer (Ap) is absorbed on the surface of carbon dots (CDs) through π-π stacking interactions, resulting in quenching of the fluorescent label by forming CD-aptamer complexes. Upon adding MB, the Ap sequences could be specifically recognized by MB, leading to the recovery of quenched fluorescence. Thus, quantitative evaluation of MB concentration has been achieved in a broad range from 50 pg mL-1 to 100 ng mL-1, and the detection limit is as low as 20 pg mL-1. This strategy is capable of specific and sensitive detection of MB in human serum, urine, and saliva and can be used for the diagnosis of AMI in the future.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: RSC Adv Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: RSC Adv Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido